Skip to content

Net margin at other companies

TEC
Bio-TechneTECH
10.9%-6.7pp
Bruker logo
BrukerBRKR
-0.6%-10.0pp
Illumina logo
IlluminaILMN
19.4%+12.7pp
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
-19.8%-7.7pp
Revvity logo
RevvityRVTY
8.3%-2.1pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
6.5%+3.4pp

Other financials

Income statement

See full
Revenue$150.8M-2.6%
Gross profit$106.2M+0.7%
Operating income-$17.0M+56.7%
Net income-$13.5M+60.8%
EPS (diluted)-$0.10+64.3%

Balance sheet

See full
Cash & equivalents$490.3M+30.0%
Total debt$81.4M+1.6%
Total equity$814.3M+15.2%
Total assets$1.0B+12.4%

Cash flow

See full
Operating cash flow$26.1M-24.0%
CapEx$1.6M-15.6%
Free cash flow$24.5M-24.4%

Valuation

See full
Market cap$4.41B+154%
Enterprise value$4B+199%
P/S6.9×+4.1×

Profitability

See full
Gross margin69.6%+1.2pp
Operating margin-6.1%-2.7pp
FCF margin19.1%

Returns & leverage

See full
Return on equity-3%-1.4pp
Debt / equity0.1×0.0×
Current ratio5.9×+0.5×

Where this comes from

Calculated from 10x Genomics, Inc.’s reported figures.

Based on trailing twelve months.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 10x Genomics, Inc.'s net margin?
10x Genomics, Inc. (TXG) reported net margin of -3.5% in Q1 2026.
How has 10x Genomics, Inc.'s net margin changed year-over-year?
10x Genomics, Inc.'s net margin increased by 85.9% year-over-year, from -25.1% to -3.5%.
What is the long-term trend for 10x Genomics, Inc.'s net margin?
Over 5 years (2020 to 2025), 10x Genomics, Inc.'s net margin has grown at a -48.2% compound annual growth rate (CAGR), from -181.6% to -6.8%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.